Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway
Open Access
- 1 September 2008
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 135 (3) , 871-881.e5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T CellsGastroenterology, 2008
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsisJournal of Experimental Medicine, 2007
- Altered macrophage differentiation and immune dysfunction in tumor developmentJournal of Clinical Investigation, 2007
- Essential crosstalk between myeloid and lymphoid cells for development of chronic colitis in myeloid‐specific signal transducer and activator of transcription 3‐deficient miceImmunology, 2007
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996